Publication | Closed Access

Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson’s disease by modulating α-synuclein aggregation and reactive oxygen species

NanoparticlesNanomedicineNanotherapeuticsReactive Oxygen SpeciesEngineeringNanomaterialsNanobiotechnologyMedicineTherapeutic NanomaterialsParkinson ’Drug Delivery SystemsNano-drug DeliveryBioimagingBiomedical Engineeringα-Synuclein AggregationPharmacologyProtein Nanoparticles